Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma - Herman, J M; Chang, D T; Goodman, K A (Cancer, 2015)
et al.